These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31281503)

  • 1. Integration of metabolomics and expression of enolase-phosphatase 1 links to hepatocellular carcinoma progression.
    Zhuang H; Qiang Z; Shao X; Wang H; Dang Y; Wang Z; Wu F; Wei W; Li Y
    Theranostics; 2019; 9(12):3639-3652. PubMed ID: 31281503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enolase-phosphatase 1 as a novel potential malignant glioma indicator promotes cell proliferation and migration.
    Su L; Yang K; Li S; Liu C; Han J; Zhang Y; Xu G
    Oncol Rep; 2018 Oct; 40(4):2233-2241. PubMed ID: 30066900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.
    Chang RM; Yang H; Fang F; Xu JF; Yang LY
    Hepatology; 2014 Oct; 60(4):1251-63. PubMed ID: 24825302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-promoting properties of enolase-phosphatase 1 in breast cancer via activating the NF-κB signaling pathway.
    Bu Y; Hao J; He J; Li X; Liu Y; Ma L
    Mol Biol Rep; 2023 Feb; 50(2):993-1004. PubMed ID: 36378417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma.
    Liu Z; Wang Y; Dou C; Xu M; Sun L; Wang L; Yao B; Li Q; Yang W; Tu K; Liu Q
    Theranostics; 2018; 8(17):4649-4663. PubMed ID: 30279729
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion.
    Ng L; Tung-Ping Poon R; Yau S; Chow A; Lam C; Li HS; Chung-Cheung Yau T; Law WL; Pang R
    Hepatology; 2013 Aug; 58(2):667-79. PubMed ID: 23504997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enolase-phosphatase 1 acts as an oncogenic driver in glioma.
    Wang B; Xu X; Liu X; Wang D; Zhuang H; He X; Han T; Hong J
    J Cell Physiol; 2021 Feb; 236(2):1184-1194. PubMed ID: 32654229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiomics Integration Reveals the Landscape of Prometastasis Metabolism in Hepatocellular Carcinoma.
    Li Y; Zhuang H; Zhang X; Li Y; Liu Y; Yi X; Qin G; Wei W; Chen R
    Mol Cell Proteomics; 2018 Apr; 17(4):607-618. PubMed ID: 29371291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of ACLY by SEC63 deploys metabolic reprogramming to facilitate hepatocellular carcinoma metastasis upon endoplasmic reticulum stress.
    Hu C; Xin Z; Sun X; Hu Y; Zhang C; Yan R; Wang Y; Lu M; Huang J; Du X; Xing B; Liu X
    J Exp Clin Cancer Res; 2023 May; 42(1):108. PubMed ID: 37122003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis.
    Ma XL; Shen MN; Hu B; Wang BL; Yang WJ; Lv LH; Wang H; Zhou Y; Jin AL; Sun YF; Zhang CY; Qiu SJ; Pan BS; Zhou J; Fan J; Yang XR; Guo W
    J Hematol Oncol; 2019 Apr; 12(1):37. PubMed ID: 30971294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
    Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
    Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma.
    Chuma M; Sakamoto M; Yasuda J; Fujii G; Nakanishi K; Tsuchiya A; Ohta T; Asaka M; Hirohashi S
    J Hepatol; 2004 Oct; 41(4):629-36. PubMed ID: 15464244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CPSF6 links alternative polyadenylation to metabolism adaption in hepatocellular carcinoma progression.
    Tan S; Zhang M; Shi X; Ding K; Zhao Q; Guo Q; Wang H; Wu Z; Kang Y; Zhu T; Sun J; Zhao X
    J Exp Clin Cancer Res; 2021 Mar; 40(1):85. PubMed ID: 33648552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling.
    Li M; Jin C; Xu M; Zhou L; Li D; Yin Y
    Cell Commun Signal; 2017 Dec; 15(1):52. PubMed ID: 29246230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
    Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
    Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HAX-1 promotes the migration and invasion of hepatocellular carcinoma cells through the induction of epithelial-mesenchymal transition via the NF-κB pathway.
    Hu YL; Feng Y; Ma P; Wang F; Huang H; Guo YB; Li P; Mao QS; Xue WJ
    Exp Cell Res; 2019 Aug; 381(1):66-76. PubMed ID: 31047882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma.
    Wu X; Chen H; Gao Q; Bai J; Wang X; Zhou J; Qiu S; Xu Y; Shi Y; Wang X; Zhou J; Fan J
    Mol Carcinog; 2014 Apr; 53(4):325-36. PubMed ID: 23169062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.